Tizanidine Tablet
Product Images NDC 50090-0811

6 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 50090-0811). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig1 (Fig1)

Fig1 (Fig1)
A line graph depicting plasma Tizanidine concentration (ng/mL) over time (hours) after dosing. It compares four conditions: 2 x 4 mg Tizanidine tablets with food, 2 x 4 mg Tizanidine tablets without food, 2 x 4 mg Tizanidine capsules with food, and 2 x 4 mg Tizanidine capsules without food, showing concentration changes over a 24-hour period.*
FDA Label Image

Fig2 (Fig2)

Fig2 (Fig2)
A line graph depicting improvement in Ashworth Score over time (hours post-dose) for 16 mg tizanidine, 8 mg tizanidine, and placebo groups. The y-axis shows improvement from -5 to 1, and the x-axis shows hours post-dose from 0 to 6. Error bars indicate variability for each data point.*
FDA Label Image

Fig3 (Fig3)

Fig3 (Fig3)
Line graph showing improvement in Ashworth Score over time for Tizanidine (mean dose 28.8 mg) compared to placebo at three points: End of Titration (Week 3), End of Maintenance (Week 7), and Endpoint (Last Observation Carried Forward). Tizanidine demonstrates greater improvement, with data points and error bars indicating variability.*
FDA Label Image

Label Image (Lbl500900811)

Label Image (Lbl500900811)
Tizanidine 2 mg oral tablets label from A-S Medication Solutions. The label indicates each tablet contains 2 mg of tizanidine hydrochloride, equivalent to 2 mg of tizanidine base. It includes storage instructions to keep at 77 degrees Fahrenheit and packaging quantity of 30 tablets. The label also shows NDC 50090-0811-0 and lot information, with a QR code and dosage package insert reference.*
FDA Label Image

Label Image (Lbl500900840)

Label Image (Lbl500900840)
Label from Tizanidine tablets, 4.5 mg tizanidine hydrochloride USP equivalent to 4 mg tizanidine base, manufactured by A-S Medication Solutions. The bottle contains 120 tablets, stored at 77 degrees Fahrenheit. The label includes the product number 5500-0 and NDC 50090-0840-0, with dosage instructions noted to seek package insert.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure diagram of Tizanidine hydrochloride, showing its molecular framework with labeled chlorine and nitrogen atoms.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.